Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

• Eli Lilly’s stock tumbles as Mounjaro, Zepbound sales miss by wide margins

  Business - MarketWatch - 55 minutes ago
• 

  Shares in weight-loss drugmaker Eli Lilly tumble on disappointing sales

  Business - Financial Times - 1 hour ago

• Honeywell’s stock falls as sales miss and lowered guidance offsets profit beat

  Business - MarketWatch - 5 days ago

• Biogen’s stock pops after earnings top estimates and company raises guidance

  Business - MarketWatch - 1 hour ago

• Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction

  Business - CNBC - 56 minutes ago

• Eli Lilly to trial use of weight loss drugs to combat unemployment in UK

  Business - CNBC - October 15
• 

  Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.

  Top stories - NBC News - October 16

• CVS cuts outlook yet again — while swapping out CEO for a company veteran

  Business - MarketWatch - October 18

More from CNBC

• U.S. economy grew at a 2.8% pace in the third quarter, less than expected

  Business - CNBC - 12 minutes ago

• Super Micro shares plunge 35% as auditor resigns after raising concerns months earlier

  Business - CNBC - 17 minutes ago

• Alphabet shares rise on earnings beats boosted by cloud revenue

  Business - CNBC - 4 hours ago

• Mortgage demand stalls as interest rates surge higher ahead of election

  Business - CNBC - 1 hour ago

• Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction

  Business - CNBC - 56 minutes ago